Literature DB >> 10494517

Nasopharyngeal cancer.

H Ali1, M al-Sarraf.   

Abstract

The current standards of treatment for nasopharyngeal cancer include 1. In early disease (stage I and stage II), radiotherapy is the treatment of choice, and the chance for cure is usually high. 2. In locally advanced disease (stage III and stage IV) combination chemotherapy and radiation therapy is indicated. Further clinical trials are warranted, which may include the newer active chemotherapeutic agents. 3. Patients with distant metastases may be treated with chemotherapy alone or other palliative measures.

Entities:  

Mesh:

Year:  1999        PMID: 10494517     DOI: 10.1016/s0889-8588(05)70096-4

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  3 in total

1.  Periostin, a stroma-associated protein, correlates with tumor invasiveness and progression in nasopharyngeal carcinoma.

Authors:  Meixiang Li; Cui Li; Danjuan Li; Yuanjie Xie; Jinfeng Shi; Guoqing Li; Yongjun Guan; Maoyu Li; Pengfei Zhang; Fang Peng; Zhiqiang Xiao; Zhuchu Chen
Journal:  Clin Exp Metastasis       Date:  2012-06-17       Impact factor: 5.150

2.  Prognostic value of tumor volume in nasopharyngeal carcinoma.

Authors:  Jeong-Hyun Kim; Joon-Kyoo Lee
Journal:  Yonsei Med J       Date:  2005-04-30       Impact factor: 2.759

3.  Salvage surgery for neck residue or recurrence of nasopharyngeal carcinoma: a 10-year experience.

Authors:  Ling Zhang; Yong-xue Zhu; Yu Wang; Cai-ping Huang; Yi Wu; Qing-hai Ji
Journal:  Ann Surg Oncol       Date:  2010-08-25       Impact factor: 5.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.